bromocriptine has been researched along with Fibrous Dysplasia of Bone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alaghband-Zadeh, J; Chung, KF; Guz, A | 1 |
Hirooka, M; Itoh, M; Nagasaka, A; Nakagawa, H; Nakagawa, K; Nakai, A; Nihei, N; Ohyama, T; Sugiura, T; Yabe, Y | 1 |
2 other study(ies) available for bromocriptine and Fibrous Dysplasia of Bone
Article | Year |
---|---|
Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.
Topics: Acromegaly; Bromocriptine; Child; Female; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypopituitarism; Hypothalamus; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone | 1983 |
Gigantism associated with McCune-Albright's syndrome.
Topics: Adolescent; Bromocriptine; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Gigantism; Growth Hormone; Humans; Levodopa; Male; Radiography; Radionuclide Imaging; Thyrotropin-Releasing Hormone | 1985 |